{"version":"1.0","provider_name":"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3","provider_url":"https:\/\/microncro.com","author_name":"info@digitalcube.jp","author_url":"https:\/\/microncro.com\/archives\/post\/author\/infodigitalcube-jp\/","title":"Video broadcasting \u201cFDA Guidance Part 2, Micron\u2019s experience\u201d | Micron, Inc. | Molecular Imaging CRO Network","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"tLk1lh6Tdf\"><a href=\"https:\/\/microncro.com\/en\/archives\/post\/video-fda-guidance-part-2\/\">Video broadcasting \u201cFDA Guidance Part 2, Micron\u2019s experience\u201d<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/microncro.com\/en\/archives\/post\/video-fda-guidance-part-2\/embed\/#?secret=tLk1lh6Tdf\" width=\"600\" height=\"338\" title=\"&#8220;Video broadcasting \u201cFDA Guidance Part 2, Micron\u2019s experience\u201d&#8221; &#8212; \u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3\" data-secret=\"tLk1lh6Tdf\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/microncro.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"In this video we briefly explain the overview of FDA Guidance, Clinical Trial Imaging Endpoint Process Standards continuing from last time. In addition, we introduce our experience how we organize high quality imaging study. FDA Guidance Clinical Trial Imaging Endpoint Process Standards Part2 -Micron\u2019s experience-","thumbnail_url":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/OGP_W1200_H630.png","thumbnail_width":1200,"thumbnail_height":630}